AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday.
The jab would be the third available for the 27-nation EU after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.
"EMA has received an application for conditional marketing authorisation for a COVID-19 vaccine developed by AstraZeneca and Oxford University," the Amsterdam-based regulator said in a statement.
The EMA said its assessment would "proceed under an accelerated timeline".
"An opinion on the marketing authorisation could be issued by 29 January... provided that the data submitted on the quality, safety and efficacy of the vaccine are sufficiently robust and complete," it said.
The EU and the EMA have been under pressure to speed up the approval of new vaccines against the virus, which has claimed the lives of more than 620,000 people across the continent.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
EU Leaders Nominate Von Der Leyen To Head Commission For 2nd Term Apple Becomes 1st Company Charged With Violating EU's Digital Markets Act Rules Concerns Mount As Hungary Assumes EU Presidency Under PM Orban Agniveer's Family Was Paid Rs 98 Lakh: Army After Rahul Gandhi's Claim Cabinet Panels Named, BJP Allies Get Highest Representation Since 2014 Rishi Sunak 2.0 Or Return Of Labour? UK Votes In Historic Polls Today "I Am Running": Biden Vows To Stay In Presidential Race Man Arrested For Criticising Bengal Minister On Social Media Acquitted DU's Faculty of Law Postpones End-Term LLB Exams Before Scheduled Date Track Latest News Live on NDTV.com and get news updates from India and around the world.